DE60219469D1 - Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika - Google Patents
Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotikaInfo
- Publication number
- DE60219469D1 DE60219469D1 DE60219469T DE60219469T DE60219469D1 DE 60219469 D1 DE60219469 D1 DE 60219469D1 DE 60219469 T DE60219469 T DE 60219469T DE 60219469 T DE60219469 T DE 60219469T DE 60219469 D1 DE60219469 D1 DE 60219469D1
- Authority
- DE
- Germany
- Prior art keywords
- antibiotics
- preparation
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0107520 | 2001-06-08 | ||
FR0107520A FR2825705B1 (fr) | 2001-06-08 | 2001-06-08 | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
PCT/FR2002/001877 WO2002100860A2 (fr) | 2001-06-08 | 2002-06-04 | Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60219469D1 true DE60219469D1 (de) | 2007-05-24 |
DE60219469T2 DE60219469T2 (de) | 2007-11-29 |
Family
ID=8864102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60219469T Expired - Lifetime DE60219469T2 (de) | 2001-06-08 | 2002-06-04 | Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika |
Country Status (15)
Country | Link |
---|---|
US (2) | US7288549B2 (de) |
EP (2) | EP1399444B1 (de) |
JP (1) | JP4509551B2 (de) |
AR (1) | AR036091A1 (de) |
AT (1) | ATE359286T1 (de) |
CA (1) | CA2449830C (de) |
CY (1) | CY1106801T1 (de) |
DE (1) | DE60219469T2 (de) |
DK (1) | DK1399444T3 (de) |
ES (1) | ES2284938T3 (de) |
FR (1) | FR2825705B1 (de) |
IL (1) | IL158756A0 (de) |
MX (1) | MXPA03011039A (de) |
PT (1) | PT1399444E (de) |
WO (1) | WO2002100860A2 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
US7439253B2 (en) * | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
DE102004004974A1 (de) * | 2004-01-31 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen |
DE102005002500A1 (de) | 2005-01-19 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen |
EP1904069B1 (de) | 2005-07-15 | 2018-06-13 | Albany Molecular Research, Inc. | Aryl- und heteroarylsubstituierte tetrahydrobenzazepine und verwendung damit zur wiederaufnahmeblockierung von norepinephrin, dopamin und serotonin |
EP2077262A4 (de) * | 2006-10-23 | 2011-12-28 | Takeda Pharmaceutical | Iminopyridinderivate und deren verwendung |
FR2914923B1 (fr) * | 2007-04-12 | 2013-06-14 | Novexel | Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens. |
FR2916444B1 (fr) * | 2007-05-25 | 2011-02-11 | Sanofi Aventis | Procede de preparation de n-carboxyanhydride enantiomeriquement enrichi. |
FR2921060B1 (fr) * | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
PT2231667E (pt) | 2008-01-18 | 2013-12-13 | Merck Sharp & Dohme | Inibidores de beta-lactamase |
US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
CL2009000964A1 (es) * | 2008-04-23 | 2010-03-26 | Takeda Pharmaceuticals Co | Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior. |
US8481569B2 (en) * | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
FR2936798B1 (fr) * | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
FR2937034B1 (fr) * | 2008-10-10 | 2012-11-23 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens |
US8410117B2 (en) | 2010-03-26 | 2013-04-02 | Hoffmann-La Roche Inc. | Imidazopyrimidine derivatives |
US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
WO2012092530A1 (en) | 2010-12-30 | 2012-07-05 | Vanderbilt University | Naphthyridinone analogs as mglur5 positive allosteric modulators |
WO2012097182A1 (en) * | 2011-01-12 | 2012-07-19 | Vanderbilt University | Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators |
US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
JP5881514B2 (ja) * | 2012-04-09 | 2016-03-09 | 株式会社トクヤマ | アミン誘導体の製造方法 |
PT2857401T (pt) | 2012-05-30 | 2019-11-19 | Meiji Seika Pharma Co Ltd | Novo inibidor de β-lactamase e método para a produção do mesmo |
UA111925C2 (uk) | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
CN103910676B (zh) * | 2013-01-04 | 2015-11-18 | 华东师范大学 | 一种多取代四氢异喹啉衍生物的合成方法 |
WO2014141132A1 (en) * | 2013-03-14 | 2014-09-18 | Naeja Pharmaceutical Inc. | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS |
WO2015046207A1 (ja) | 2013-09-24 | 2015-04-02 | Meiji Seikaファルマ株式会社 | ジアザビシクロオクタン誘導体の製造法とその中間体 |
SG11201602723RA (en) | 2013-10-08 | 2016-05-30 | Meiji Seika Pharma Co Ltd | Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative |
WO2016081452A1 (en) * | 2014-11-17 | 2016-05-26 | Entasis Therapeutics Limited | Combination therapy for treatment of resistant bacterial infections |
RU2732129C2 (ru) | 2014-12-05 | 2020-09-11 | Мейдзи Сейка Фарма Ко., Лтд. | Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата |
CN107438614B (zh) * | 2015-04-03 | 2020-01-31 | 拜欧蒂姆公司 | 杂环化合物及它们在预防或治疗细菌感染中的应用 |
EP3075381A1 (de) * | 2015-04-03 | 2016-10-05 | Mutabilis | Heterocyclische verbindungen und deren verwendung zur vorbeugung oder behandlung von bakteriellen infektionen |
EP3184529A1 (de) | 2015-12-23 | 2017-06-28 | Mutabilis | Heterocyclische verbindungen und deren verwendung zur vorbeugung oder behandlung von bakteriellen infektionen |
US10800778B2 (en) * | 2016-09-16 | 2020-10-13 | Entasis Therapeutics Limited | Beta-lactamase inhibitor compounds |
JOP20190061A1 (ar) | 2016-09-28 | 2019-03-26 | Novartis Ag | مثبطات بيتا-لاكتاماز |
EP3300736B1 (de) * | 2016-09-30 | 2021-05-05 | Mutabilis | Zusammensetzung mit einer antibiotischen verbindung und heterocyclischen verbindung und deren verwendung bei der vorbeugung oder behandlung bakterieller infektionen |
CN108239089B (zh) * | 2016-12-27 | 2020-05-22 | 浙江医药股份有限公司新昌制药厂 | 一种阿维巴坦钠的合成方法 |
WO2018129008A1 (en) | 2017-01-04 | 2018-07-12 | Entasis Therapeutics Inc. | Compounds and methods for treating bacterial infections |
EP3357924A1 (de) * | 2017-02-06 | 2018-08-08 | Mutabilis | Neuartige heterocyclische verbindungen und deren verwendung bei der vorbeugung oder behandlung von bakteriellen infektionen |
EA037916B1 (ru) * | 2017-02-08 | 2021-06-07 | Энтасис Терапеутикс Лимитед | Соединения-ингибиторы бета-лактамаз |
LT3630111T (lt) | 2017-05-08 | 2022-03-10 | Entasis Therapeutics, Inc. | Junginiai ir būdai, skirti bakterinių infekcijų gydymui |
CN109400521B (zh) * | 2017-08-18 | 2020-05-08 | 新发药业有限公司 | 一种改进的5r-苄氧氨基哌啶-2s-甲酸酯、其草酸盐的制备方法 |
CN109678855B (zh) | 2017-10-18 | 2020-07-17 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
CN109678856B (zh) | 2017-10-18 | 2020-09-25 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
CN109956941B (zh) * | 2017-12-25 | 2020-08-04 | 新发药业有限公司 | 一种阿维巴坦的简便制备方法 |
CN108276408B (zh) * | 2018-04-19 | 2020-09-29 | 上海皓元医药股份有限公司 | 一种曲贝替定的中间体及其制备方法和用途 |
EP3604315A1 (de) * | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclische verbindungen und deren verwendung in der vorbeugung oder behandlung von bakteriellen infektionen |
EP3604309A1 (de) | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclische verbindungen und deren verwendung in der vorbeugung oder behandlung von bakteriellen infektionen |
CN111978321A (zh) * | 2020-09-22 | 2020-11-24 | 海南梵圣生物科技有限公司 | 一种4-Boc-2,5,6,7-四氢吡唑并[4,3-b]吡啶及其衍生物的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654282A (en) * | 1969-08-21 | 1972-04-04 | Houde Lab | 1 2 3 4-tetrahydro-isoquinoline 1-carboxylic acids |
US3629265A (en) * | 1969-10-30 | 1971-12-21 | Hoffmann La Roche | 7-halo-4-isoquinolones |
AU626427B2 (en) * | 1989-06-09 | 1992-07-30 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
JPH05339263A (ja) * | 1992-06-08 | 1993-12-21 | Wakunaga Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
EP1227103B1 (de) * | 1993-09-29 | 2006-07-26 | Nabi | Ringerweiterte Nukleoside und Nukleotide |
ATE177099T1 (de) * | 1993-12-29 | 1999-03-15 | Pfizer | Diazabicyclische neurokinin antagonisten |
EP0702004A2 (de) * | 1994-09-15 | 1996-03-20 | Ciba-Geigy Ag | 2,9-Diamino- und 2-amino-8-carbamoyl-4-hydroxy-alkansäureamid-derivative |
GB9505538D0 (en) * | 1995-03-18 | 1995-05-03 | Ciba Geigy Ag | New compounds |
SE9504618D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Ab | New Compounds |
TW527355B (en) * | 1997-07-02 | 2003-04-11 | Bristol Myers Squibb Co | Inhibitors of farnesyl protein transferase |
US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
EP1070054A1 (de) * | 1998-04-08 | 2001-01-24 | Takeda Chemical Industries, Ltd. | Aminverbindungen, ihre herstellung und ihre verwendung als somatostatin rezeptor antagonisten oder agonisten |
GB9818731D0 (en) * | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
CN1285588C (zh) * | 1998-12-18 | 2006-11-22 | 先灵公司 | 法尼基蛋白转移酶抑制剂 |
WO2001025228A1 (fr) * | 1999-10-07 | 2001-04-12 | Tadeka Chemical Industries, Ltd. | Derives d'amines |
AU2001246893A1 (en) * | 2000-04-18 | 2001-10-30 | Sumitomo Pharmaceuticals Company, Limited | Tricyclic quinazolinediones |
WO2002051231A1 (en) * | 2000-12-22 | 2002-07-04 | Basf Aktiengesellschaft | Genes of corynebacterium |
US7179921B2 (en) * | 2001-02-22 | 2007-02-20 | School Of Pharmacy, University Of London | Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
-
2001
- 2001-06-08 FR FR0107520A patent/FR2825705B1/fr not_active Expired - Fee Related
-
2002
- 2002-06-04 JP JP2003503627A patent/JP4509551B2/ja not_active Expired - Fee Related
- 2002-06-04 EP EP02778894A patent/EP1399444B1/de not_active Expired - Lifetime
- 2002-06-04 CA CA2449830A patent/CA2449830C/en not_active Expired - Fee Related
- 2002-06-04 US US10/480,019 patent/US7288549B2/en not_active Expired - Fee Related
- 2002-06-04 DE DE60219469T patent/DE60219469T2/de not_active Expired - Lifetime
- 2002-06-04 WO PCT/FR2002/001877 patent/WO2002100860A2/fr active IP Right Grant
- 2002-06-04 ES ES02778894T patent/ES2284938T3/es not_active Expired - Lifetime
- 2002-06-04 MX MXPA03011039A patent/MXPA03011039A/es unknown
- 2002-06-04 AT AT02778894T patent/ATE359286T1/de active
- 2002-06-04 IL IL15875602A patent/IL158756A0/xx unknown
- 2002-06-04 PT PT02778894T patent/PT1399444E/pt unknown
- 2002-06-04 DK DK02778894T patent/DK1399444T3/da active
- 2002-06-04 EP EP07007308A patent/EP1798231A3/de not_active Ceased
- 2002-06-07 AR ARP020102156A patent/AR036091A1/es not_active Application Discontinuation
-
2007
- 2007-06-07 US US11/810,981 patent/US8148540B2/en not_active Expired - Fee Related
- 2007-07-02 CY CY20071100876T patent/CY1106801T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1798231A3 (de) | 2008-02-27 |
JP4509551B2 (ja) | 2010-07-21 |
PT1399444E (pt) | 2007-05-31 |
FR2825705A1 (fr) | 2002-12-13 |
WO2002100860A2 (fr) | 2002-12-19 |
CA2449830C (en) | 2012-11-27 |
CY1106801T1 (el) | 2012-05-23 |
US20070299108A1 (en) | 2007-12-27 |
AR036091A1 (es) | 2004-08-11 |
IL158756A0 (en) | 2004-05-12 |
JP2005518333A (ja) | 2005-06-23 |
EP1399444A2 (de) | 2004-03-24 |
DE60219469T2 (de) | 2007-11-29 |
MXPA03011039A (es) | 2004-03-19 |
CA2449830A1 (en) | 2002-12-19 |
US8148540B2 (en) | 2012-04-03 |
ATE359286T1 (de) | 2007-05-15 |
US20050245505A1 (en) | 2005-11-03 |
FR2825705B1 (fr) | 2005-05-20 |
EP1399444B1 (de) | 2007-04-11 |
US7288549B2 (en) | 2007-10-30 |
ES2284938T3 (es) | 2007-11-16 |
EP1798231A2 (de) | 2007-06-20 |
WO2002100860A3 (fr) | 2003-11-20 |
DK1399444T3 (da) | 2007-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60219469D1 (de) | Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika | |
DE50207522D1 (de) | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
DE50312949D1 (de) | Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
DE50309807D1 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
DE50113328D1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE50111293D1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
ATE305456T1 (de) | Bizyklische heterozyklen, diese verbindungen enthaltende zusammenstellungen,und verfahren zu deren herstellung | |
DE50110906D1 (de) | Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
DE502004008951D1 (de) | Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE50111799D1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE50114874D1 (de) | Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
DE60208373D1 (de) | Polyaryleneether-polyolefinzusammensetzung, verfahren zu deren herstellung und formassen daraus | |
DE602004029236D1 (de) | Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren | |
DE50300813D1 (de) | Neue fluorencarbonsaureester, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
DE60100246D1 (de) | Polyxylosidderivate, Verfahren zu deren Herstellung, Zusammensetzung und Verwendung als Tensid | |
DE502004002117D1 (de) | Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung | |
DE50313017D1 (de) | Ringsubstituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
DE602004029245D1 (de) | Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen | |
ATE327981T1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
DE602004031165D1 (de) | Arylvinylazacycloalkan-Verbindungen und Verfahren zu deren Herstellung und Verwendung | |
DE112004002104A5 (de) | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung | |
DE602004010229D1 (de) | Polyenpolyketide, verfahren zu deren herstellung und deren verwendung als pharmazeutikum | |
DE60306693D1 (de) | Heterozyklische Verbindungen enthaltende opthalmische Gegenstände und Verfahren zu deren Herstellung | |
DE50011179D1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE10081263D2 (de) | Schraubverbindung und Verbindungsmittel hierfür sowie Verfahren zu deren Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |